-
Mashup Score: 0The Role of HGF/MET Signaling in Metastatic Uveal Melanoma - 2 year(s) ago
Hepatocyte growth factor (HGF)/mesenchymal-epithelial transition factor (MET) signaling promotes tumorigenesis and tumor progression in various types of cancer, including uveal melanoma (UM). The roles of HGF/MET signaling have been studied in cell survival, proliferation, cell motility, and migration. Furthermore, HGF/MET signaling has emerged as a critical player not only in the tumor itself…
Source: MDPICategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Log in or sign up to view - 2 year(s) ago
See posts, photos and more on Facebook.
Source: www.facebook.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Sidney Kimmel Cancer Center Physician Spotlight: Rino Seedor, MD: https://t.co/G9i8uDUYYq #UvealMelanoma #OcularMelanoma #SkinCancer #CutaneousMelanoma https://t.co/WM5PhwmUEM
-
-
Mashup Score: 0Log In or Sign Up to View - 3 year(s) ago
See posts, photos and more on Facebook.
Source: www.facebook.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Many patients with advanced #UvealMelanoma seek treatment from our Metastatic Uveal Melanoma Program, which provides patients with the opportunity to be seen by multiple oncology specialists, in one location and in one visit: https://t.co/lglj9uMK72 #OcularMelanoma #EyeCancer https://t.co/1MKPpumvTW
-
-
Mashup Score: 1
Original Article from The New England Journal of Medicine — Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Source: New England Journal of MedicineCategories: Latest Headlines, Oncologists1Tweet-
Finally a significant advance in treating this poorly responsive disease #OcularMelanoma https://t.co/Vov2JSvijM
-
-
Mashup Score: 1A Life Saving Reminder - Loren’s Rare Cancer Journey - NORD (National Organization for Rare Disorders) - 3 year(s) ago
In 2001, I was diagnosed with ocular melanoma. What makes ocular melanoma rare is that only 2,500 people are diagnosed with it each year. Following my diagnosis in October of 2001, I went through numerous tests at Sylvester Cancer Center. In November, I was admitted into the hospital where they implanted a metal plate into my left eye with 20 seeds of radiation, which was removed after a week. …
Categories: Latest Headlines, Rare DiseaseTweet-
“It could save your life.” Loren shares her journey with #OcularMelanoma & stresses the importance of yearly eye exams in honor of #RareCancerDay on September 30. Read her story here: https://t.co/YQ5BFROYnI https://t.co/LHu4lmhIKA
-
-
Mashup Score: 0Melanoma Research Foundation Launches Historic Patient-Reported Ocular Melanoma Registry | Melanoma Research Foundation - 3 year(s) ago
The MRF’s CURE Ocular Melanoma (CURE OM) initiative announces the first-of-its-kind patient-reported registry to accelerate the pace of research and treatment development, transforming the scientific understanding of this rare disease. WASHINGTON, DC, May 10 – The Melanoma Research Foundation’s (MRF) CURE OM initiative today announces the launch of the Virtual Information System to Improve […]
Source: Melanoma Research FoundationCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
.@CureMelanoma's CURE OM initiative has launched the Virtual Information System to Improve Outcomes & Networks (VISION) Registry, a 1st of its kind patient-reported & driven #ocularmelanoma registry. SKCC's Dr. Marlana Orloff is on the steering committee: https://t.co/GbGWlWnFV2
-
-
Mashup Score: 2Program Planner - 3 year(s) ago
One fine body?
Source: www.abstractsonline.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Check out this #JeffersonResearch on multiomics profiling of #BAP1 loss in #uvealmelanoma during the virtual #AACR21 Annual Meeting: https://t.co/JiNK4B7cRO @AndrewEAplin #ocularmelanoma https://t.co/O2eBDB99Xz
-
-
Mashup Score: 0Defactinib (VS-6063) Combined With VS-6766 in Patients With Metastatic Uveal Melanoma - Full Text View - ClinicalTrials.gov - 3 year(s) ago
Defactinib (VS-6063) Combined With VS-6766 in Patients With Metastatic Uveal Melanoma – Full Text View.
Source: www.clinicaltrials.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Learn more about this phase II #clinicaltrial led by SKCC's Takami Sato, MD, PhD, Director of Jefferson's Metastatic Uveal Melanoma Program: https://t.co/rbeaM32qs0 @VerastemOncolog #uvealmelanoma #ocularmelanoma #clinicalresearch #defactinib #TrialTuesday https://t.co/S9R2R7b69z
-
-
Mashup Score: 0Retinal Physician - SUBSPECIALTY NEWS: Ultracool anesthesia for IVI, self-reported IVI events, promising data for gene therapies, and more. - 3 year(s) ago
Retinal Physician presents the latest news on industry and clinical research into therapies for retinal diseases.
Source: Retinal PhysicianCategories: Latest Headlines, OphthalmologyTweet-
Aura Biosciences said its light-activated intravitreal therapy for #ocularmelanoma has been shown to preserve an average of 91% of vision. Scroll to "Aura Biosciences Therapy Preserves Vision in Ocular Melanoma." https://t.co/7IXxaEVVDq
-
-
Mashup Score: 5
First positive Phase 3 clinical trial for any T cell receptor therapeutic and first for any bispecific in a solid tumor Tebentafusp has the potential to be the first new therapy to improve OS in patients with metastatic uveal melanoma in 40 years (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 23 November 2020) Immunocore (the…
Source: ImmunocoreCategories: Hem/Oncs, Latest HeadlinesTweet-
Improved overall survival in #uvealmelanoma with tebentafusp #immunotherapy - great news patients with #ocularmelanoma! Can't wait to data! How to seq w ipi-nivo? Finally options in this really tough form of #melanoma! @alexshoushtari @DrSapnaPatel https://t.co/GuNn65nM7p https://t.co/AyOkpqYLeB
-
In a new review in Cancers, SKCC's Dr. Takami Sato & team analyze various functions of HGF/MET signaling contributing to metastatic formation in #UvealMelanoma, as well as review resistance to treatments in metastatic disease: https://t.co/7QLCYiuLG6 #OcularMelanoma #EyeCancer